Literature DB >> 24821282

Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation.

Dan-Ju Luo1, Qiong Feng, Zhi-Hao Wang, Dong-Sheng Sun, Qun Wang, Jian-Zhi Wang, Gong-Ping Liu.   

Abstract

Phosphotyrosyl phosphatase activator (PTPA) is decreased in the brains of Alzheimer's disease (AD) and the AD transgenic mouse models. Here, we investigated whether down-regulation of PTPA affects cell viability and the underlying mechanisms. We found that PTPA was located in the integral membrane of mitochondria, and knockdown of PTPA induced cell apoptosis in HEK293 and N2a cell lines. PTPA knockdown decreased mitochondrial membrane potential and induced Bax translocation into the mitochondria with a simultaneous release of Cyt C, activation of caspase-3, cleavage of poly (DNA ribose) polymerase (PARP), and decrease in Bcl-xl and Bcl-2 protein levels. Over-expression of Protein phosphatase 2A (PP2A) catalytic subunit (PP2AC ) did not rescue the apoptosis induced by PTPA knockdown, and PTPA knockdown did not affect the level of and their phosphorylation of mitogen-activated protein kinases (MAPKs), indicating that PP2A and MAPKs were not involved in the apoptosis induced by PTPA knockdown. In the cells with over-expression of tau, PTPA knockdown induced PP2A inhibition and tau hyperphosphorylation but did not cause significant cell death. These data suggest that PTPA deficit causes apoptotic cell death through mitochondrial pathway and simultaneous tau hyperphosphorylation attenuates the PTPA-induced cell death. Phosphotyrosyl phosphatase activator (PTPA) is decreased in the brains of Alzheimer's disease (AD) and AD transgenic mouse models. Here, we investigated whether down-regulation of PTPA affects cell viability. We found that PTPA located in the integral membrane of mitochondria, and knockdown of PTPA induced cell apoptosis in HEK293 and N2a cell lines by decreasing mitochondrial membrane potential, which leads to translocation of Bax and a simultaneous release of Cyt C. In the cells with tau over-expression, PTPA knockdown inactivated PP2A to phosphorylate tau to avoid cell apoptosis which induced by PTPA knockdown.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; Apoptosis; Cyt C; PTPA; mitochondrial pathway; tau hyperphosphorylation

Mesh:

Substances:

Year:  2014        PMID: 24821282     DOI: 10.1111/jnc.12761

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Authors:  A Zamò; J Pischimarov; M Schlesner; P Rosenstiel; R Bomben; H Horn; T Grieb; T Nedeva; C López; A Haake; J Richter; L Trümper; C Lawerenz; W Klapper; P Möller; M Hummel; D Lenze; M Szczepanowski; L Flossbach; M Schreder; V Gattei; G Ott; R Siebert; A Rosenwald; E Leich
Journal:  Leukemia       Date:  2017-08-21       Impact factor: 11.528

Review 2.  Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.

Authors:  Rong-Hong Ma; Yao Zhang; Xiao-Yue Hong; Jun-Fei Zhang; Jian-Zhi Wang; Gong-Ping Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

3.  Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA receptor expression.

Authors:  Xiao-Guang Li; Xiao-Yue Hong; Ya-Li Wang; Shu-Juan Zhang; Jun-Fei Zhang; Xia-Chun Li; Yan-Chao Liu; Dong-Shen Sun; Qiong Feng; Jin-Wang Ye; Yuan Gao; Dan Ke; Qun Wang; Hong-Lian Li; Keqiang Ye; Gong-Ping Liu; Jian-Zhi Wang
Journal:  EMBO Rep       Date:  2019-05-13       Impact factor: 8.807

4.  Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.

Authors:  Guo-Biao Xu; Pei-Pei Guan; Pu Wang
Journal:  Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.590

Review 5.  Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.

Authors:  Ya-Qing Li; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-11-04       Impact factor: 5.590

Review 6.  Mitochondrial Biology and Neurological Diseases.

Authors:  Siddharth Arun; Lei Liu; Gizem Donmez
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 7.  Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms.

Authors:  Ying Yang; Jian-Zhi Wang
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer.

Authors:  Shinsuke Hanawa; Akira Mitsuhashi; Makio Shozu
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

9.  Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins.

Authors:  Xia-Chun Li; Yu Hu; Zhi-hao Wang; Yu Luo; Yao Zhang; Xiu-Ping Liu; Qiong Feng; Qun Wang; Keqiang Ye; Gong-Ping Liu; Jian-Zhi Wang
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

10.  Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin.

Authors:  Yu Hu; Xia-Chun Li; Zhi-hao Wang; Yu Luo; Xiangnan Zhang; Xiu-Ping Liu; Qiong Feng; Qun Wang; Zhenyu Yue; Zhong Chen; Keqiang Ye; Jian-Zhi Wang; Gong-Ping Liu
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.